✦ LIBER ✦

Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer

✍ Scribed by Lester S. Borden Jr.; Peter E. Clark; James Lovato; M. Craig Hall; Diana Stindt; Michele Harmon; Randi M. Mohler; Frank M. Torti

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 148 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinorelbine and estramustine in androgen

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer : A Phase II study

✍ Matthew R. Smith; Donald Kaufman; William Oh; Kimberly Guerin; Michael Seiden; T 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

CK2 signaling in androgen-dependent and

CK2 signaling in androgen-dependent and -independent prostate cancer

✍ Guixia Wang; Kashif A. Ahmad; Gretchen Unger; Joel W. Slaton; Khalil Ahmed 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract Protein serine/threonine kinase casein kinase 2 (CK2) is a key player in cell growth and proliferation but is also a potent suppressor of apoptosis. CK2 has been found to be dysregulated in all the cancers that have been examined, including prostate cancer. Investigations of CK2 signali

Phase II trial of oral cyclophosphamide,

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma

✍ Beth Hellerstedt; Kenneth J. Pienta; Bruce G. Redman; Peg Esper; Rodney Dunn; Ju 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND The authors evaluated the combination of oral cyclophosphamide, oral prednisone, and diethylstilbestrol (DES) in patients with androgen‐independent prostate carcinoma (AIPC). ## METHODS Thirty‐seven patients with prostate carcinoma refractory to androgen ablation who ha

Role of antioxidant systems in human and

Role of antioxidant systems in human androgen-independent prostate cancer cells

✍ Suzuki, Yasutomo; Kondo, Yukihiro; Himeno, Seiichiro; Nemoto, Kaoru; Akimoto, Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

## BACKGROUND. Most prostate cancer cells respond to initial hormonal therapy; however, some of them eventually acquire resistance to the hormonal therapy. Hormone-independent prostate cancer usually exhibits resistance to chemotherapy and radiotherapy. Antioxidant systems are known to be involved

Androgen axis in prostate cancer

✍ Zoran Culig; Georg Bartsch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

## Abstract Endocrine therapy for advanced prostate cancer is based on androgen ablation or blockade of the androgen receptor (AR). AR action in prostate cancer has been investigated in a number of cell lines, their derivatives, and transgenic animals. AR expression is heterogenous in prostate canc

Bone extracellular matrix induces homeob

Bone extracellular matrix induces homeobox proteins independent of androgens: Possible mechanism for androgen-independent growth in human prostate cancer cells

✍ Robbins, Steven E.; Shu, Wei-Ping; Kirschenbaum, Alexander; Levine, Alice C.; Mi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

## BACKGROUND. Differences in gene expression in prostate cells are believed to be secondary to epithelial-stromal interactions. We theorized that bone matrix may provide a fertile "soil" for prostate cancer by inducing androgen-dependent genes and allowing for androgen-independent growth. METHODS